Picture of Zhongzhi Pharmaceutical Holdings logo

3737 Zhongzhi Pharmaceutical Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapContrarian

Annual cashflow statement for Zhongzhi Pharmaceutical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line15616761.8131
Depreciation
Amortisation
Non-Cash Items-14.8-20.129.8-11.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital-36.8-1541.7168.8
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities16893.2178285
Capital Expenditures-74.9-126-188-89.1
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items18.3-12451.9103
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-56.6-250-13613.4
Financing Cash Flow Items1.50.60.02
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-64.9-71.9-40.8-68.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash47.6-2292.35228